Hydroxyurea-induced denaturation of norm
โ
D. Roa; P. Kopsombut; M. d. P. Aguinaga; E. A. Turner
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 104 KB
๐ 2 views
Use of hydroxyurea (HU) to treat sickle cell disease is usually associated with increments in fetal hemoglobin (Hb F) production; however, in vitro studies show that HU may also induce hemoglobin denaturation. Whole blood samples from Hb AA, Hb AS, and Hb SS patients were treated in vitro with 100,